MAGEA3 and neoplasm: proved that MAGE-A3-specific CD8+ T cells could be isolated from the peripheral blood of patients with EC and that CD8+T cells could react with MAGE-A3 peptide; consequently, these CD8+T cells could specifically lyse certain tumor cells (43).